Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Higgs

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 1995
Molecular mechanisms and therapeutic strategies related to nitric oxideS Moncada, E A Higgs
Clinics in Haematology|May 1, 1986
Arachidonate metabolism in blood cells and the vessel wallS Moncada, E A Higgs
Blood Reviews|June 1, 1987
Prostaglandins in the pathogenesis and prevention of vascular diseaseS Moncada, E A Higgs
Handbook of Experimental Pharmacology|September 27, 2006
Nitric oxide and the vascular endotheliumS Moncada, E A Higgs
British Journal of Pharmacology|January 13, 2006
The discovery of nitric oxide and its role in vascular biologyS Moncada, E A Higgs
Hypertension (Dallas, Tex. : 1979)|October 1, 1988
The discovery of nitric oxide as the endogenous nitrovasodilatorS Moncada, R M Palmer, E A Higgs
Prostaglandins|August 1, 1978
Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat pawE A Higgs, S Moncada, J R Vane
Lancet (London, England)|January 1, 1977
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregationS Moncada, E A Higgs, J R Vane
British Journal of Pharmacology|July 1, 1978
Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouchE A Higgs, G A Higgs, S Moncada, et al.
Prostaglandins|July 1, 1978
Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendotheliumE A Higgs, S Moncada, J R Vane, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 1995
Molecular mechanisms and therapeutic strategies related to nitric oxideS Moncada, E A Higgs
Clinics in Haematology|May 1, 1986
Arachidonate metabolism in blood cells and the vessel wallS Moncada, E A Higgs
Blood Reviews|June 1, 1987
Prostaglandins in the pathogenesis and prevention of vascular diseaseS Moncada, E A Higgs
Handbook of Experimental Pharmacology|September 27, 2006
Nitric oxide and the vascular endotheliumS Moncada, E A Higgs
British Journal of Pharmacology|January 13, 2006
The discovery of nitric oxide and its role in vascular biologyS Moncada, E A Higgs
Hypertension (Dallas, Tex. : 1979)|October 1, 1988
The discovery of nitric oxide as the endogenous nitrovasodilatorS Moncada, R M Palmer, E A Higgs
Prostaglandins|August 1, 1978
Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat pawE A Higgs, S Moncada, J R Vane
Lancet (London, England)|January 1, 1977
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregationS Moncada, E A Higgs, J R Vane
British Journal of Pharmacology|July 1, 1978
Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouchE A Higgs, G A Higgs, S Moncada, et al.
Prostaglandins|July 1, 1978
Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendotheliumE A Higgs, S Moncada, J R Vane, et al.
Pageof 2